Subscribe to RSS
DOI: 10.1055/a-2768-2636
Management of Infants Born to Pregnant Women with Reactive Syphilis Serology: Resource Saving from Using the Current Centers for Disease Control Guidelines
Authors
Abstract
Objective
There has been a marked increase in the number of infants admitted to neonatal intensive care units (NICUs) in Canada for treatment of congenital syphilis. We studied the impact on resource utilization from using the Centers for Disease Control (CDC) guidelines that allow use of a single-dose intramuscular benzathine penicillin G (BPG), as compared with 10-day course of intravenous penicillin G (PG), in infants considered at low risk for congenital syphilis.
Study Design
This was a retrospective cohort study enrolling infants born to mothers with reactive syphilis serology and admitted for management to two Level 2 NICUs in Edmonton, Alberta, Canada, over a 2-year period. Data were extracted for key NICU resources that are used in managing these infants. We then estimated the resources that would be utilized if the entire cohort was managed per the current CDC guidelines.
Results
Forty-nine infants met the study criteria of which 42 were treated with 10-day course of PG. Of these 42 infants, 21 (50%) met the CDC criteria for a single dose of BPG. The use of the CDC criteria to manage this cohort could have avoided 244 hospital days, 128 central line days, 168 antibiotic days related to congenital syphilis treatment, 23 long bones X-rays, and 17 lumbar punctures, for an estimated savings of CDC $ 263,000 to the provincial health system.
Conclusion
Using the current CDC guidelines, half of the infants exposed to maternal syphilis and treated with a 10-day course of PG in our cohort could have been managed with a single dose of BPG, resulting in a significant saving of health care resources and in hospital costs.
Key Points
-
Cases of congenital syphilis have risen sharply in parts of Canada.
-
Frequent admissions of such cases in the Canadian NICUs have aggravated bed capacity challenges.
-
Applying the current CDC guidelines could reduce the NICU length of stay, the use of central lines, and other invasive procedures in this population.
Contributors' Statement
The manuscript has been read and approved by all authors.
Publication History
Received: 06 November 2025
Accepted: 08 December 2025
Accepted Manuscript online:
11 December 2025
Article published online:
23 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Salomè S, Cambriglia MD, Scarano SM. et al. Congenital syphilis in the twenty-first century: an area-based study. Eur J Pediatr 2023; 182 (01) 41-51
- 2 Gilmour LS, Walls T. Congenital syphilis: a review of global epidemiology. Clin Microbiol Rev 2023; 36 (02) e0012622
- 3 Canada Communicable Disease Report (CCDR), Volume 49-10. Infectious syphilis and congenital syphilis in Canada, 2022 . Accessed April 13, 2025 at: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-10-october-2023/infectious-congenital-syphilis-canada-2022.html
- 4 Nelson CRM, Ferro A, Naczk K. et al Brief report: trends of congenital syphilis among neonates in Canada 2012-2023. J Pediatr Clin Pract 2025; 16: 200146
- 5 Workowski KA, Bachmann LH, Chan PA. et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70 (04) 1-187
- 6 Congenital syphilis—STI treatment guidelines. Centers for Disease Control. Accessed May 1, 2025 at: https://www.cdc.gov/std/treatment-guidelines/congenital-syphilis.htm
- 7 Fanella S, Bitnun A, Barton M, Sauve L. Diagnosis and management of congenital syphilis – avoiding missed opportunities. 2024 . Accessed April 13, 2025 at: https://cps.ca/en/documents/position/congenital-syphilis
- 8 Stafford IA, Workowski KA, Bachmann LH. Syphilis complicating pregnancy and congenital syphilis. N Engl J Med 2024; 390 (03) 242-253
- 9 Sheffield JS, Sánchez PJ, Morris G. et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 2002; 186 (03) 569-573
- 10 Medoro AK, Sánchez PJ. Syphilis in neonates and infants. Clin Perinatol 2021; 48 (02) 293-309
- 11 Paryani SG, Vaughn AJ, Crosby M, Lawrence S. Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 1994; 125 (03) 471-475
- 12 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
- 13 Robinson JL, Tse-Chang A, Fanella S. Controversies in the management of congenital syphilis. J Assoc Med Microbiol Infect Dis Can 2024; 9 (04) 204-207
- 14 Lim J, Yoon SJ, Shin JE. et al. Outcomes of infants born to pregnant women with syphilis: a nationwide study in Korea. BMC Pediatr 2021; 21 (01) 47
- 15 Ito Y, Yamagishi T, Ikenoue C. et al. Clinical practice guidelines for the management of congenital syphilis in Japan, 2023: executive summary. Pediatr Infect Dis J 2025; 44 (03) e90-e94
